Sustained Virologic Response [setrvalá virologická odpověď]

topical
20
Terms

Sustained Viral Suppression

Persistent link   https://www.medvik.cz/link/D000072230
Definition

The continuous, long-term suppression of VIRAL LOAD, generally to undetectable levels, as the result of treatment with ANTIVIRAL AGENTS.

DUI
D000072230 MeSH Browser
CUI
M000616660
Previous indexing
Antiviral Agents/therapeutic use (1999-2016); Drug Therapy, Combination (1999-2016); Treatment Outcome (1999-2016)
History note
2017
Public note
2017

E Analytical, Diagnostic and Therapeutic Techniques and Equipment
E01 Diagnosis 1 794
E01.789 Prognosis 9 767
E01.789.800 Treatment Outcome 21 964
E01.789.800.190 Disease-Free Survival 1 453
E01.789.800.238 Early Termination of Clinical Trials 17
E01.789.800.262 Pathologic Complete Response 7
E01.789.800.285 Progression-Free Survival 537
E01.789.800.379 Response Evaluation Criteria in Solid Tumors 43
E01.789.800.570 Sustained Virologic Response 20
E01.789.800.665 Therapeutic Index 6
E01.789.800.713 Treatment Expectations
E01.789.800.760 Treatment Failure 689

N Health Care
N04 Health Services Administration 1 755
N04.761 Quality of Health Care 2 509
N04.761.559 Outcome and Process Assessment, Health Care 1 870
N04.761.559.590 Outcome Assessment, Health Care 587
N04.761.559.590.800 Treatment Outcome 21 964
N04.761.559.590.800.190 Disease-Free Survival 1 453
N04.761.559.590.800.379 Early Termination of Clinical Trials 17
N04.761.559.590.800.427 Pathologic Complete Response 7
N04.761.559.590.800.474 Progression-Free Survival 537
N04.761.559.590.800.569 Response Evaluation Criteria in Solid Tumors 43
N04.761.559.590.800.665 Sustained Virologic Response 20
N04.761.559.590.800.713 Therapeutic Index 6
N04.761.559.590.800.737 Treatment Expectations
N04.761.559.590.800.760 Treatment Failure 689
N05 Health Care Quality, Access, and Evaluation 689
N05.715 Quality of Health Care 2 509
N05.715.360 Health Care Evaluation Mechanisms 202
N05.715.360.575 Outcome and Process Assessment, Health Care 1 870
N05.715.360.575.575 Outcome Assessment, Health Care 587
N05.715.360.575.575.800 Treatment Outcome 21 964
N05.715.360.575.575.800.190 Disease-Free Survival 1 453
N05.715.360.575.575.800.379 Early Termination of Clinical Trials 17
N05.715.360.575.575.800.427 Pathologic Complete Response 7
N05.715.360.575.575.800.474 Progression-Free Survival 537
N05.715.360.575.575.800.569 Response Evaluation Criteria in Solid Tumors 43
N05.715.360.575.575.800.665 Sustained Virologic Response 20
N05.715.360.575.575.800.713 Therapeutic Index 6
N05.715.360.575.575.800.737 Treatment Effect Heterogeneity 1
N05.715.360.575.575.800.749 Treatment Expectations
N05.715.360.575.575.800.760 Treatment Failure 689

Add